SPONIX Skin Care Looks to Be America's Choice in Nail and Feet Wellness
August 11 2009 - 6:00AM
Marketwired
Experts agree that an estimated 30 to 35 million Americans have
ochyomitosis, or nail fungus, and a recent survey by the American
Podiatric Medical Association showed that nearly 40 percent of
Americans reel from heel pain. It's time we get to the bottom of
these feet problems.
"Ochyomitosis and painful feet are probably the most common
problems in podiatry," said Jack Amin, President and CEO of
AmexDrug Corp. (OTCBB: AXRX), parent company to BioRx
Pharmaceuticals, a subsidiary that manufactures the SPONIX and
BACTIVEX skin care product line. "With many options out there, I
want Americans to know that our all-natural SPONIX foot care
products are the economical way to treat their feet."
SPONIX Nail Gel is a natural, non-toxic, water-free formulation
that encourages healing by removing keratin build-up from under the
nail bed, effectively restoring strength to the nail. It helps
protect the new keratin cells that emerge from below the cuticle
skin and helps resolve the discomfort associated with unsightly
nails.
SPONIX Foot Spray is podiatrist and dermatologist recommended.
Its special formula works by delivering a high concentration of
deep penetrating natural ingredients that have long been renowned
and used by Naturalists and Herbalists for their antiseptic,
anti-fungal, germicidal and anti-microbial properties.
"Topical treatments have big advantages over procedures like the
PinPointe FootLaser treatment, cleared by the FDA last year, which
can cost up to a thousand dollars," said Amin. "The availability of
over-the-counter products, like our SPONIX and BACTIVEX line, has a
very low risk of serious side effects, are water- and alcohol-free,
diabetic friendly and inexpensive."
About AmexDrug Corporation (OTCBB: AXRX):
AmexDrug Corp. is a vertically integrated pharmaceutical and
cosmeceutical company. With its subsidiaries BioRx Pharmaceuticals,
Dermagen, Inc., and Allied Med, Inc., AmexDrug Corp. develops,
manufactures, markets, and distributes private-label
over-the-counter pharmaceuticals, innovative skin care products and
prescription packaging to the nation's largest wholesalers and
distributors. In addition, the company distributes prescription
drugs to independent pharmacies. AmexDrug Corp. has an experienced
executive team, advanced manufacturing facility and broad
distribution network, allowing the company to integrate various
phases of operations into one efficient business entity. For more
information about AmexDrug Corp., please visit
www.amexdrug.com.
Contact AmexDrug Corp. Jack Amin President and CEO (310)
855-0475 jack.amin@amexdrug.com
AmexDrug (CE) (USOTC:AXRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
AmexDrug (CE) (USOTC:AXRX)
Historical Stock Chart
From Sep 2023 to Sep 2024